Among my hundred questions about this enterprise — notwithstanding the ethics of performing clinical trials in hospice patients, as is related in the Times article – is this: does the dye harm the kidneys? As for how much it costs, that’s not said either. Because Alzheimer’s is a fairly common disease and memory loss an even commoner condition, the potential demand for this marketable diagnostic method might be great. What are we thinking?
See more The New Alzheimer’s Plaque Test (and early breast cancer detection)
